Mesenchymal stem cells reverse thymus aging by reprogramming the DNA methylation of thymic epithelial cells.

Zailing Yang, Chuan Tian, Zhixu He, Xiangqing Zhu, Jie He, Hang Pan, Ye Li, Guangping Ruan, XiJun Wu, Xinghua Pan

The Basic Medical Laboratory of the 920th Hospital of Joint Logistics Support Force of PLA, The Transfer Medicine Key Laboratory of Cell Therapy Technology of Yunan Province, The Integrated Engineering Laboratory of Cell Biological Medicine of State and Regions, Kunming 650032, Yunnan Province, China. · pubmed

Paper

Abstract

A decrease in the number and activity of thymic epithelial cells (TECs) is an important factor in thymic degeneration. Mesenchymal stem cells (MSCs) treating thymic ageing is a promising strategy, but the DNA methylation modification mechanism in TECs remains unclear.

The following analysis is generated by AI and may contain errors. It is separate from the authors’ abstract and is not peer review.

Research summary

The paper addresses the aging of thymic epithelial cells, which is a significant factor in thymic degeneration and immune system aging. By exploring the role of mesenchymal stem cells in reversing thymus aging through DNA methylation reprogramming, it contributes to understanding potential interventions that target the root causes of aging. However, while the findings are solid, they may not have a transformative impact on the broader field of longevity research at this stage.

Author of this paper? Send a correction.